Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 31

Sort by

Sort Order Select

Journal Articles

CYT-338 NK Cell Engager Mutispecific Antibody Engagement of NKp46 Activation Receptor Overcomes Anti-CD38 Mab Mediated Fratricide of NK Cells and Accords Enhanced Cancer Immunotherapy

Vishal Khairnar, Liang Lin, Hao-Ming Chang, Sourindra Maiti, Solgalim Diaz, Ofer Mandelboim, Tariq Mughal, Dan Chiche, Elisabetta Burchi, Armand Bensussan, Jean Kadouche, Ola Landgren, Dickran Kazandjian, Armin Rath, Daniel Teper, Wei Li, Antonio Arulanandam

Blood (2023) 142 (Supplement 1): 6725.

https://doi.org/10.1182/blood-2023-190613

Published: 2023

Journal Articles

Biological Characterization and Differential Gene Expression Analysis of CYT-338 NK Cell Engager (NKE) Against CD38 Expressing Tumors Including Multiple Myeloma (MM)

Liang Lin, Hao-Ming Chang, Dennis Wu, Ben Titz, Amy Chen, Marshall Chao Ma, Preeti Ashok, David Zou, Nejmi Dilmac, Armand Bensussan, Jean Kadouche, Chorom Pak, Stanley Frankel, Daniel Teper, Wei Li, Antonio Arulanandam

Blood (2022) 140 (Supplement 1): 7068–7069.

https://doi.org/10.1182/blood-2022-170193

Published: 2022

Journal Articles

Involvement of the CD39/CD73/adenosine pathway in T-cell proliferation and NK cell-mediated antibody-dependent cell cytotoxicity in Sézary syndrome

Gabrielle Sonigo, Alizée Bozonnat, Maëlle Dumont, Nicolas Thonnart, Caroline Ram-Wolff, Adèle de Masson, Martine Bagot, Armand Bensussan, Anne Marie-Cardine

Blood (2022) 139 (17): 2712–2716.

https://doi.org/10.1182/blood.2021014782

Published: 2022

Includes: Supplemental data

Journal Articles

Chimerized Anti-ICOS 314.8 Monoclonal Antibodies Inhibit Tumor Cells and Regulatory T Cells in Patients with Sézary Syndrome

Florent Amatore, Mathilde Barré, Florence Orlanducci, Marc Lopez, Remy Castellano, Caroline Ram-Wolff, Laurent Gorvel, Armelle Goubard, Caroline Gaudy-Marqueste, Martine Bagot, Armand Bensussan, Emmanuel Delaporte, Daniel Olive

Blood (2021) 138 (Supplement 1): 2260.

https://doi.org/10.1182/blood-2021-153345

Published: 2021

Journal Articles

ICOS Is Widely Expressed in Cutaneous T-Cell Lymphoma and Its Targeting Promotes Potent Killing of Malignant Cells

Florent Amatore, Nicolas Ortonne, Marc Lopez, Mathilde Barré, Florence Orlanducci, Remy Castellano, Saskia Ingen-Housz-Oro, Amandine De Croos, Laurent Gorvel, Armelle Goubard, Reda Bouabdallah, Jean Marc Schiano De Colella, Jean-Jacques Grob, Philippe Gaulard, Martine Bagot, Armand Bensussan, Emmanuel Delaporte, Daniel Olive

Blood (2021) 138 (Supplement 1): 790.

https://doi.org/10.1182/blood-2021-150677

Published: 2021

Journal Articles

Argx-110 for Treatment of CD70-Positive Advanced Cutaneous T-Cell Lymphoma in a Phase 1/2 Clinical Trial

Blood (2018) 132 (Supplement 1): 1627.

https://doi.org/10.1182/blood-2018-99-118204

Published: 2018

Journal Articles

KIR3DL2 expression in cutaneous T-cell lymphomas: expanding the spectrum for KIR3DL2 targeting

Maxime Battistella, Christophe Leboeuf, Caroline Ram-Wolff, Charlotte Hurabielle, Cécile Bonnafous, Hélène Sicard, Armand Bensussan, Martine Bagot, Anne Janin

Blood (2017) 130 (26): 2900–2902.

https://doi.org/10.1182/blood-2017-06-792382

Published: 2017

Includes: Supplemental data

Journal Articles

Circulating and skin-derived Sézary cells: clonal but with phenotypic plasticity

Marie Roelens, Marc Delord, Caroline Ram-Wolff, Anne Marie-Cardine, Antonio Alberdi, Guitta Maki, Laurence Homyrda, Armand Bensussan, Martine Bagot, Antoine Toubert, Hélène Moins-Teisserenc

Blood (2017) 130 (12): 1468–1471.

https://doi.org/10.1182/blood-2017-03-772996

Published: 2017

Includes: Supplemental data

Journal Articles

First-in-Human, Multicenter Phase I Study of IPH4102, First-in-Class Humanized Anti-KIR3DL2 Monoclonal Antibody, in Relapsed/Refractory Cutaneous T-Cell Lymphomas: Preliminary Safety, Exploratory and Clinical Activity Results

Blood (2016) 128 (22): 1826.

https://doi.org/10.1182/blood.V128.22.1826.1826

Published: 2016

Journal Articles

CD24 hi CD27 + and plasmablast-like regulatory B cells in human chronic graft-versus-host disease

Blood (2015) 125 (11): 1830–1839.

https://doi.org/10.1182/blood-2014-09-599159

Published: 2015

Includes: Supplemental data

Journal Articles

KIR3DL2 is a coinhibitory receptor on Sézary syndrome malignant T cells that promotes resistance to activation-induced cell death

Nicolas Thonnart, Anne Caudron, Isabel Legaz, Martine Bagot, Armand Bensussan, Anne Marie-Cardine

Blood (2014) 124 (22): 3330–3332.

https://doi.org/10.1182/blood-2014-09-598995

Published: 2014

Journal Articles

Localized edema with sclerodermatous evolution: a possible form of skin chronic graft-versus-host disease associated with endothelial activation

Mathilde Tardieu, Michel Rybojad, Régis Peffault de Latour, Marie Robin, Adèle de Masson, Aliénor Xhaard, Hélène Le Buanec, Nathalie Parquet, Flore Sicre de Fontbrune, Anne Bergeron, Catherine Scieux, Valérie Dessirier, Armand Bensussan, Martine Bagot, Gérard Socié, Jean-David Bouaziz

Blood (2013) 122 (3): 463–465.

https://doi.org/10.1182/blood-2013-03-488148

Published: 2013

Journal Articles

Inducible expression and pathophysiologic functions of T-plastin in cutaneous T-cell lymphoma

Elodie Bégué, Francette Jean-Louis, Martine Bagot, Sébastien Jauliac, Jean-Michel Cayuela, Liliane Laroche, Nathalie Parquet, Hervé Bachelez, Armand Bensussan, Gilles Courtois, Laurence Michel

Blood (2012) 120 (1): 143–154.

https://doi.org/10.1182/blood-2011-09-379156

Published: 2012

Includes: Supplemental data

Journal Articles

Differential and tumor-specific expression of CD160 in B-cell malignancies

Timothy W. Farren, Jerome Giustiniani, Feng-Ting Liu, Dimitris A. Tsitsikas, Marion G. Macey, James D. Cavenagh, Heather E. Oakervee, David Taussig, Adrian C. Newland, Maria Calaminici, Armand Bensussan, Michael Jenner, John G. Gribben, Samir G. Agrawal

Blood (2011) 118 (8): 2174–2183.

https://doi.org/10.1182/blood-2011-02-334326

Published: 2011

Includes: Supplemental data

Journal Articles

IgA-mediated human autoimmune hemolytic anemia as a result of hemagglutination in the spleen, but independent of complement activation and FcαRI

Philippe Chadebech, Marc Michel, Daniel Janvier, Kazunori Yamada, Christiane Copie-Bergman, Gwellaouen Bodivit, Armand Bensussan, Jean-Jacques Fournie, Bertrand Godeau, Philippe Bierling, Shozo Izui, France Noizat-Pirenne

Blood (2010) 116 (20): 4141–4147.

https://doi.org/10.1182/blood-2010-03-276162

Published: 2010

Includes: Supplemental data

Journal Articles

A novel KIR-associated function: evidence that CpG DNA uptake and shuttling to early endosomes is mediated by KIR3DL2

Simona Sivori, Michela Falco, Simona Carlomagno, Elisa Romeo, Cristiana Soldani, Armand Bensussan, Antonella Viola, Lorenzo Moretta, Alessandro Moretta

Blood (2010) 116 (10): 1637–1647.

https://doi.org/10.1182/blood-2009-12-256586

Published: 2010

Includes: Supplemental data

Journal Articles

CD160 signaling mediates PI3K-dependent survival and growth signals in chronic lymphocytic leukemia

Feng-Ting Liu, Jerome Giustiniani, Timothy Farren, Li Jia, Armand Bensussan, John G. Gribben, Samir G. Agrawal

Blood (2010) 115 (15): 3079–3088.

https://doi.org/10.1182/blood-2009-08-239483

Published: 2010

Includes: Supplemental data

Journal Articles

Spontaneous in Vitro Death of CLL Cells Can Be Prevented by Mitochondrial Stabilization Via CD160 Signaling.

Feng-Ting Liu, MB, PhD, Li Jia, MB, PhD, Timothy Farren, BSc(HONS), MIBMS, Jerome Giustiniani, Armand Bensussan, John G. Gribben, MD, DSc, Samir G Agrawal, MD, PhD

Blood (2009) 114 (22): 4372.

https://doi.org/10.1182/blood.V114.22.4372.4372

Published: 2009

Journal Articles

Regulatory T cells differentially modulate the maturation and apoptosis of human CD8 + T-cell subsets

Maria Nikolova, Jean-Daniel Lelievre, Matthieu Carriere, Armand Bensussan, Yves Lévy

Blood (2009) 113 (19): 4556–4565.

https://doi.org/10.1182/blood-2008-04-151407

Published: 2009

Includes: Supplemental data

Journal Articles

Dual Action of CD160 on CLL Cells: Giving Life to Prepare for Death!.

Sami r G Agrawal, MD, PhD, Feng-Ting Liu, MB, PhD, Jerome Giustiniani, PhD, Li Jia, MB, PhD, John G. Gribben, MD, DSc, Armand Bensussan, PhD

Blood (2008) 112 (11): 2088.

https://doi.org/10.1182/blood.V112.11.2088.2088

Published: 2008

NARROW

CYT-338 NK Cell Engager Mutispecific Antibody Engagement of NKp46 Activation Receptor Overcomes Anti-CD38 Mab Mediated Fratricide of NK Cells and Accords Enhanced Cancer Immunotherapy

Biological Characterization and Differential Gene Expression Analysis of CYT-338 NK Cell Engager (NKE) Against CD38 Expressing Tumors Including Multiple Myeloma (MM)

Involvement of the CD39/CD73/adenosine pathway in T-cell proliferation and NK cell-mediated antibody-dependent cell cytotoxicity in Sézary syndrome

Chimerized Anti-ICOS 314.8 Monoclonal Antibodies Inhibit Tumor Cells and Regulatory T Cells in Patients with Sézary Syndrome

ICOS Is Widely Expressed in Cutaneous T-Cell Lymphoma and Its Targeting Promotes Potent Killing of Malignant Cells

Argx-110 for Treatment of CD70-Positive Advanced Cutaneous T-Cell Lymphoma in a Phase 1/2 Clinical Trial

KIR3DL2 expression in cutaneous T-cell lymphomas: expanding the spectrum for KIR3DL2 targeting

Circulating and skin-derived Sézary cells: clonal but with phenotypic plasticity

First-in-Human, Multicenter Phase I Study of IPH4102, First-in-Class Humanized Anti-KIR3DL2 Monoclonal Antibody, in Relapsed/Refractory Cutaneous T-Cell Lymphomas: Preliminary Safety, Exploratory and Clinical Activity Results

CD24 hi CD27 + and plasmablast-like regulatory B cells in human chronic graft-versus-host disease

KIR3DL2 is a coinhibitory receptor on Sézary syndrome malignant T cells that promotes resistance to activation-induced cell death

Localized edema with sclerodermatous evolution: a possible form of skin chronic graft-versus-host disease associated with endothelial activation

Inducible expression and pathophysiologic functions of T-plastin in cutaneous T-cell lymphoma

Differential and tumor-specific expression of CD160 in B-cell malignancies

IgA-mediated human autoimmune hemolytic anemia as a result of hemagglutination in the spleen, but independent of complement activation and FcαRI

A novel KIR-associated function: evidence that CpG DNA uptake and shuttling to early endosomes is mediated by KIR3DL2

CD160 signaling mediates PI3K-dependent survival and growth signals in chronic lymphocytic leukemia

Spontaneous in Vitro Death of CLL Cells Can Be Prevented by Mitochondrial Stabilization Via CD160 Signaling.

Regulatory T cells differentially modulate the maturation and apoptosis of human CD8 + T-cell subsets

Dual Action of CD160 on CLL Cells: Giving Life to Prepare for Death!.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only